MedPath

Combined tDCS and Vision Restoration Training in Post-acute Stroke: an Exploratory Efficacy and Safety Study

Phase 1
Completed
Conditions
Hemianopia
Stroke
Interventions
Device: verum tDCS
Device: sham tDCS
Behavioral: VRT
Registration Number
NCT02703870
Lead Sponsor
University of Magdeburg
Brief Summary

The purpose of this Study is to determine whether non-invasive transcranial direct current stimulation (tDCS) is effective in increasing rehabilitation effects after stroke in visual Cortex.

Detailed Description

Visual field defects after posterior cerebral artery stroke can be improved by vision restoration training (VRT), but when combined with transcranial direct current stimulation (tDCS) which alters brain excitability, vision restoration can be potentiated in the chronic stage. Because it is possible that such therapy may be more effective during the early recovery phase after the stroke and can reach patients during the rehabilitation phase, investigators wished to explore the applicability, efficacy and safety of early intervention with a combined tDCS/VRT treatment.

19 post-acute stroke homonymous hemianopia patients were randomly assigned to either 10 sessions of combined rea-tDCS (2mA, 10 daily sessions of 15-20 min) and VRT, or sham-tDCS and VRT. The primary outcome criterion was the pre-post change in perimetric detection thresholds. Secondary outcome is neurophysiological changes in EEG measures (VEP, Connectivity, Spectral Power, ...)

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
19
Inclusion Criteria
  • Posterior Cerebral Artery Stroke
  • Visual Field Defect
  • Lesion age 4 weeks up to 6 month max.
Exclusion Criteria
  • Electrical Implants
  • Metal artefacts in head
  • Epilepsy
  • Visual Neglect

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Verum tDCSVRTVerum group receiving complete treatment of tDCS
real VRTverum tDCSReal Vision Restoration Training
sham tDCSVRTSham group receiving sham tDCS
Verum tDCSverum tDCSVerum group receiving complete treatment of tDCS
sham tDCSsham tDCSSham group receiving sham tDCS
real VRTsham tDCSReal Vision Restoration Training
Primary Outcome Measures
NameTimeMethod
Change of mean sensitivity (in dB) detection threshold from baseline to post-intervention and follow up14-20 days post treatment, 3 months follow up
Secondary Outcome Measures
NameTimeMethod
Change in power spectra (Volts-squared per Hz (V^2/Hz) from baseline to post-intervention and follow up14-20 days post treatment, 3 months follow up

power spectra (Volts-squared per Hz (V\^2/Hz)

Change in VEP amplitudes (µV) from baseline to post-intervention and follow up14-20 days post treatment, 3 months follow up

VEP amplitudes (µV)

Change in network coherence from baseline to post-intervention and follow up14-20 days post treatment, 3 months follow up

network coherence correlations

Number of participants with treatment-related adverse events assessed by a questionnaireup to 4 months

questionnaire recording adverse effects

Change in VEP latencies (ms) from baseline to post-intervention and follow up14-20 days post treatment, 3 months follow up

VEP latencies (ms)

Trial Locations

Locations (2)

Inst. f. Medical Psychology, Univ. of Magdeburg

🇩🇪

Magdeburg, Germany

Neurologisches Therapiezentrum Gmundnerberg

🇦🇹

Altmuenster, Austria

© Copyright 2025. All Rights Reserved by MedPath